Logo National Institutes of Health Office of Extramural Research National Institutes of Health Logo
Grants and Funding
NIH Human Embryonic Stem Cell Registry
Research Using This Line is Eligible for NIH Funding

Detailed information for selected cell line:

Cell Line: UCLA 7; disease-specific mutation/abnormal karyotype
NIH Registration Number: 0143
NIH Approval Number: NIHhESC-12-0143
Available for Distribution: Other - possibly in future: contact speckman@mednet.ucla.edu
Provider Restrictions: hESC recipients must provide documentation of of ESCRO, IRB, or equivalent ethical review for the reseach planned with the requested line.

NIH Restrictions: (No Additional Restrictions)
Additional Information: UCLA 7 (47, XX+13) was karyotyped at passage 7 after derivation. Cytogenic analysis of the resulting hESC line was performed on twenty G-banded metaphase cells and all twenty cells demonstrated trisomy 13. No other karyotypic abnormality was identified. Trisomy 13 is a genetic disorder also referred to as Patau syndrome.

Submitting Organization: University of California, Los Angeles
Provider Name: Steven Peckman
Provider Phone: 310-794-4919
Provider Email: speckman@mednet.ucla.edu
Provider URL: www.stemcell.ucla.edu
Approval Date: 01/12/2012

View All Lines Eligible for Use

Go to NIH Form 2890 Login Page

Go to NIH Stem Cell Information Page

Related Resources

    NIH Form 2890:

  • Login Page
    (Authorization Required)
    Contact Us:

  • Email questions to:

  • (Emails that are offensive or unrelated to stem cells will be deleted.)

This page last updated on July 13, 2011
Content Manager: stemcell@mail.nih.gov 
Technical Issues: E-mail OER Webmaster